ARVEE

Arvee Laboratories (India) Financial Results

₹211.15-2.65%
Market cap
₹233 crore
P/E
57.4
P/B
6.89
ROE
7.8%
Dividend yield
1.20%

For the year ended Mar 2021, Arvee Laboratories (India) reported revenue of ₹47 crore and net profit of ₹3 crore, against ₹40 crore and ₹3 crore a year earlier.

Arvee Laboratories (India) annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Arvee Laboratories (India) annual profit and loss (₹ crore)
ItemMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue47406130383141
Expenses41355427352836
Operating profit6673435
Operating margin %13%14%12%10%9%10%13%
Other income1011111
Interest1000000
Depreciation2221111
Profit before tax4362325
Tax %26%25%33%43%25%-4%11%
Net profit3341234
EPS (₹)0.000.003.740.951.952.293.68
Dividend payout %———————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Arvee Laboratories (India) financial results — frequently asked questions

What is Arvee Laboratories (India)'s annual revenue and net profit?

For the financial year ended Mar 2021, Arvee Laboratories (India)'s revenue was ₹47 crore and net profit ₹3 crore; net profit was unchanged from ₹3 crore in Mar 2022.

How fast has Arvee Laboratories (India) grown over three years?

From Mar 2024 to Mar 2021, Arvee Laboratories (India)'s revenue grew at a compound annual rate of 16.1% and net profit at 44.2%. Past growth does not indicate future results.

What is the EPS of Arvee Laboratories (India)?

Annual EPS for Mar 2021 was ₹0.00.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Arvee Laboratories (India) With ATS

Track ARVEE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.